CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-12 | Bancel Stephane Chief Executive Officer | Sale | −20,500 | $187.44 | $3.8M | 5,411,946 |
| 2023-01-12 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,867,155 | ||
| 2023-01-11 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-01-11 | Bancel Stephane Chief Executive Officer | Sale | −7,780 | $183.15 | $1.4M | 5,444,166 |
| 2023-01-11 | Bancel Stephane Chief Executive Officer | Sale | −5,578 | $184.43 | $1.0M | 5,438,588 |
| 2023-01-11 | Bancel Stephane Chief Executive Officer | Sale | −15,957 | $185.14 | $3.0M | 5,422,631 |
| 2023-01-11 | Bancel Stephane Chief Executive Officer | Sale | −10,685 | $186.50 | $2.0M | 5,411,946 |
| 2023-01-11 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,907,155 | ||
| 2023-01-11 | AFEYAN NOUBAR Director | Sale | −10,000 | $188.57 | $1.9M | 2,257,209 |
| 2023-01-05 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-01-05 | Bancel Stephane Chief Executive Officer | Sale | −10,749 | $172.64 | $1.9M | 5,441,197 |
| 2023-01-05 | Bancel Stephane Chief Executive Officer | Sale | −14,816 | $173.42 | $2.6M | 5,426,381 |
| 2023-01-05 | Bancel Stephane Chief Executive Officer | Sale | −13,460 | $174.38 | $2.3M | 5,412,921 |
| 2023-01-05 | Bancel Stephane Chief Executive Officer | Sale | −975 | $175.10 | $171K | 5,411,946 |
| 2023-01-05 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,947,155 | ||
| 2023-01-04 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-01-04 | Bancel Stephane Chief Executive Officer | Sale | −2,950 | $176.20 | $520K | 5,448,996 |
| 2023-01-04 | Bancel Stephane Chief Executive Officer | Sale | −11,450 | $177.38 | $2.0M | 5,437,546 |
| 2023-01-04 | Bancel Stephane Chief Executive Officer | Sale | −16,097 | $178.25 | $2.9M | 5,421,449 |
| 2023-01-04 | Bancel Stephane Chief Executive Officer | Sale | −7,291 | $179.12 | $1.3M | 5,414,158 |
Page 61 of 66 · 1,314 trades